Filed: 5/15/2026ACC: 0001964437-26-000005
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $552.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$552.22M
Total AUM (reported)
46.68M
Total Shares
Allocation by class
COM$388.74M70.4%
SPONSORED ADS$60.43M10.9%
COM NEW$52.09M9.4%
SHS USD$30.81M5.6%
ORDINARY SHARES$13.74M2.5%
CLASS A ORD SHS$4.40M0.8%
COM SHS$2.00M0.4%
Portfolio Concentration
Top 3$191.43M34.7%
4–10$233.92M42.4%
11–25$126.86M23.0%
Top 3 weight
34.7%
Top 10 weight
77.0%
Voting Authority Distribution
Total shares with voting rights: 46.68M
Sole
Full voting authority
46.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
ALUMIS INC
SOLEShares3.20M
TypeSH
Market value$70.54M
12.77%
Sole
3.20M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares4.35M
TypeSH
Market value$60.46M
10.95%
Sole
4.35M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares542.70K
TypeSH
Market value$60.43M
10.94%
Sole
542.70K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares824.53K
TypeSH
Market value$47.91M
8.68%
Sole
824.53K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.20M
TypeSH
Market value$33.94M
6.15%
Sole
1.20M
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
SOLEShares3.69M
TypeSH
Market value$33.65M
6.09%
Sole
3.69M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares281.90K
TypeSH
Market value$32.18M
5.83%
Sole
281.90K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares162.96K
TypeSH
Market value$30.81M
5.58%
Sole
162.96K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares449.93K
TypeSH
Market value$28.77M
5.21%
Sole
449.93K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares6.46M
TypeSH
Market value$26.67M
4.83%
Sole
6.46M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares626.63K
TypeSH
Market value$24.12M
4.37%
Sole
626.63K
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares345.63K
TypeSH
Market value$18.94M
3.43%
Sole
345.63K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares966.61K
TypeSH
Market value$17.52M
3.17%
Sole
966.61K
Shared
0.00
None
0.00
INVIVYD INC
SOLEShares10.95M
TypeSH
Market value$14.23M
2.58%
Sole
10.95M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares2.90M
TypeSH
Market value$14.19M
2.57%
Sole
2.90M
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares516.76K
TypeSH
Market value$13.74M
2.49%
Sole
516.76K
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares4.17M
TypeSH
Market value$9.25M
1.68%
Sole
4.17M
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3.86M
TypeSH
Market value$6.49M
1.18%
Sole
3.86M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares739.96K
TypeSH
Market value$4.40M
0.80%
Sole
739.96K
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares89K
TypeSH
Market value$2.00M
0.36%
Sole
89K
Shared
0.00
None
0.00
SATELLOS BIOSCIENCE INC
SOLEShares350K
TypeSH
Market value$1.97M
0.36%
Sole
350K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALUMIS INCSOLE | COM | 3.20M | SH | $70.54M 12.77% | 3.20M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 4.35M | SH | $60.46M 10.95% | 4.35M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 542.70K | SH | $60.43M 10.94% | 542.70K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 824.53K | SH | $47.91M 8.68% | 824.53K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.20M | SH | $33.94M 6.15% | 1.20M | 0.00 | 0.00 |
IMMIX BIOPHARMA INCSOLE | COM | 3.69M | SH | $33.65M 6.09% | 3.69M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 281.90K | SH | $32.18M 5.83% | 281.90K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 162.96K | SH | $30.81M 5.58% | 162.96K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 449.93K | SH | $28.77M 5.21% | 449.93K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 6.46M | SH | $26.67M 4.83% | 6.46M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 626.63K | SH | $24.12M 4.37% | 626.63K | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 345.63K | SH | $18.94M 3.43% | 345.63K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 966.61K | SH | $17.52M 3.17% | 966.61K | 0.00 | 0.00 |
INVIVYD INCSOLE | COM | 10.95M | SH | $14.23M 2.58% | 10.95M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 2.90M | SH | $14.19M 2.57% | 2.90M | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 516.76K | SH | $13.74M 2.49% | 516.76K | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 4.17M | SH | $9.25M 1.68% | 4.17M | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.86M | SH | $6.49M 1.18% | 3.86M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 739.96K | SH | $4.40M 0.80% | 739.96K | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 89K | SH | $2.00M 0.36% | 89K | 0.00 | 0.00 |
SATELLOS BIOSCIENCE INCSOLE | COM | 350K | SH | $1.97M 0.36% | 350K | 0.00 | 0.00 |